ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,868, issued on June 16, was assigned to Baylor College of Medicine (Houston).

"Uses of A2 domain of von Willebrand factor" was invented by Miguel Angel Cruz (Pearland, Texas) and Trung Nguyen (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the disclosure encompass methods and compositions for maintaining a healthy fibrin network in an individual. The disclosure includes methods of targeting fibrin in an individual for the purpose of restoring fibrin that is subject to a level of fibrinolysis that is deleterious, such as excessive or reduced with respect to the general population. Such modifications of fibrin in an individual m...